No common founder for C9orf72 expansion mutation in Sweden.

Huei-Hsin Chiang, Charlotte Forsell, Anna-Karin Lindström, Lena Lilius, Håkan Thonberg, Inger Nennesmo, Caroline Graff
Author Information
  1. Huei-Hsin Chiang: Department of NVS, Division for Neurogeriatrics, Karolinska Institutet, Center for Alzheimer Research, Huddinge, Sweden.
  2. Charlotte Forsell: Department of NVS, Division for Neurogeriatrics, Karolinska Institutet, Center for Alzheimer Research, Huddinge, Sweden.
  3. Anna-Karin Lindström: Department of NVS, Division for Neurogeriatrics, Karolinska Institutet, Center for Alzheimer Research, Huddinge, Sweden.
  4. Lena Lilius: Department of NVS, Division for Neurogeriatrics, Karolinska Institutet, Center for Alzheimer Research, Huddinge, Sweden.
  5. Håkan Thonberg: Department of NVS, Division for Neurogeriatrics, Karolinska Institutet, Center for Alzheimer Research, Huddinge, Sweden.
  6. Inger Nennesmo: Department of Laboratory Medicine, Division of Pathology, Karolinska University Hospital, Stockholm, Sweden.
  7. Caroline Graff: Department of NVS, Division for Neurogeriatrics, Karolinska Institutet, Center for Alzheimer Research, Huddinge, Sweden.

Abstract

Hexanucleotide expansion mutations in the chromosome 9 open reading frame 72 (C9orf72) gene is the most common genetic cause for frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). SNP haplotype analyses have suggested that all C9orf72 expansion mutations originate from a common founder. However, not all C9orf72 expansion mutation carriers have the same haplotype. To investigate if the C9orf72 expansion mutation carriers in Sweden share a common founder, we have genotyped SNPs flanking the C9orf72 expansion mutation in cases with FTD, FTD-ALS or ALS to perform haplotype analysis. We have genotyped 57 SNPs in 232 cases of which 45 carried the C9orf72 expansion mutation. Two risk haplotypes consisting of 31 SNPs, spanning 131 kbp, were found to be significantly associated with the mutation. In summary, haplotype analysis on Swedish C9orf72 expansion mutation carriers indicates that the C9orf72 expansion mutation arose on at least two risk haplotypes.

References

  1. Eur J Hum Genet. 2013 Jan;21(1):102-8 [PMID: 22692064]
  2. Nature. 2011 Aug 10;476(7359):214-9 [PMID: 21833088]
  3. Lancet Neurol. 2010 Oct;9(10 ):978-85 [PMID: 20801718]
  4. Neuron. 2011 Oct 20;72(2):245-56 [PMID: 21944778]
  5. Neurobiol Aging. 2012 Jan;33(1):209.e3-8 [PMID: 21925771]
  6. Hum Mutat. 2013 Feb;34(2):363-73 [PMID: 23111906]
  7. Lancet Neurol. 2012 Apr;11(4):323-30 [PMID: 22406228]
  8. Neuron. 2011 Oct 20;72(2):257-68 [PMID: 21944779]
  9. Lancet Neurol. 2012 Jan;11(1):54-65 [PMID: 22154785]

MeSH Term

Adult
Aged
Aged, 80 and over
Amyotrophic Lateral Sclerosis
C9orf72 Protein
DNA Repeat Expansion
Female
Frontotemporal Dementia
Haplotypes
Humans
Male
Middle Aged
Polymorphism, Single Nucleotide
Proteins
Sweden

Chemicals

C9orf72 Protein
C9orf72 protein, human
Proteins